Predictors of favorable long-term outcomes in first-line surgery for microprolactinomas
In patients with microprolactinomas, first-line surgery presents a favorable prospect for reducing reliance on DAs. However, for those with high PRL levels ≥ 290 µg/L at diagnosis, first-line surgery is not recommended, as the majority of them require adjuvant DA therapy in the long term.
Authors
- Emanuel Christ (ORCID: https://orcid.org/0000-0002-5604-4606)
- Lukas Andereggen (ORCID: https://orcid.org/0000-0003-1764-688X)
Institutions
- University of Bern (CH)
- Bern University of Applied Sciences (CH)
- University Hospital of Basel (CH)
- Kantonsspital Aarau (CH)
Publication Details
- Journal
- Journal of Neuro-Oncology
- Published
- 2025-02-04
- DOI
- https://doi.org/10.1007/s11060-025-04958-6
- Citations
- 4
- Primary Topic
- Pituitary Gland Disorders and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 5.18